EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adipokines in Neuroendocrine Tumors: An Evaluation of the Serum Levels of Ghrelin and Leptin

Janusz Strzelczyk iD, Agnes Bocian-Jastrzębska iD, Joanna Katarzyna Strzelczyk iD, Monika Wójcik-Giertuga, Krzysztof Biernacki iD, Dariusz Kajdaniuk iD, Beata Kos-Kudła iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25189820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Janusz Strzelczyk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medica…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Ghrelin, Leptin, Neuroendocrine Tumors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine tumors (NETs) are a heterogeneous group of tumors that are characteristically different from other malignancies. The difference is not only in the prognosis, which is usually more favorable in such patients, but also in the high clinical progression of the disease, where NET patients do not experience the cachexia typical of other malignancies. The purposes of this study were to evaluate the ghrelin and leptin levels in a group of patients diagnosed with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and bronchopulmonary neuroendocrine tumors (BP-NETs) and to analyze the relationship between the body mass index (BMI), cachexia and selected NET markers. The study group comprised 52 patients with GEP-NETs and BP-NETs, while the controls comprised 67 healthy volunteers. The ghrelin and leptin concentrations were determined in both groups. The concentrations of chromogranin A, serotonin, 5-hydroxyindoleacetic acid (5-HIAA), total cholesterol, triglycerides and glucose were determined in the study group. Characteristics of the study group and of the controls were defined by age, sex and BMI, and the effects of these factors on the ghrelin and leptin concentrations were assessed. The data obtained were subject to statistical analysis. The study cohort showed higher levels of ghrelin as compared to the controls (142.31 ± 26.00 vs. 121.49 ± 35.45, p = 0.016), and no statistical difference in the levels of leptin (11.15 ± 9.6 vs. 12.94 ± 20.30, p = 0.439) were observed. Significantly lower levels of leptin were found in patients with the small intestine primary location, as compared to individuals with primary locations in the lungs and the pancreas (4.9 ± 6.49 vs. 16.97 ± 15.76, p = 0.045, and 4.9 ± 6.49 vs. 12.89 ± 8.56, p = 0.016, respectively). A positive correlation was observed between the leptin levels and the BMIs in both the study group (rS = 0.33, p = 0.016) and the controls (rS = 0.41, p = 0.001). The study group showed a negative correlation between the leptin levels and 5-HIAA (rS = −0.32, p = 0.026) and a negative correlation between the leptin levels and Ki-67 (rS = −0.33, p = 0.018). The control group showed negative correlations between the ghrelin and the volunteer age (rS = −0.41, p = 0.008), the leptin and the volunteer age (rS = −0.44, p < 0.001), the leptin and total cholesterol (rS = −0.24, p < 0.049) as well as the leptin and triglycerides (rS = −0.33, p < 0.006). The current study emphasized the importance of the markers’ determination, where ghrelin appears as a valuable diagnostic biomarker in NETs, probably responsible for maintaining a normal BMI, despite the progression of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorGhrelinLeptinNeuroendocrine TumorsAdultAgedFemaleHumansMaleMiddle AgedAdipokinesBody Mass IndexCachexiaCase-Control StudiesIntestinal NeoplasmsPancreatic NeoplasmsStomach Neoplasms

Stichwörter der Autor:innen

adipokinescachexiaghrelinleptinneuroendocrine tumors

Substanzen

AdipokinesBiomarkers, TumorGhrelinLEP protein, humanLeptin

Autor:innen und Institutionen

  • Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-514 Katowice, Poland.
  • Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.
  • Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.

ORCID-Profile: Janusz Strzelczyk, Agnes Bocian-Jastrzębska, Joanna Katarzyna Strzelczyk, Krzysztof Biernacki, Dariusz Kajdaniuk, Beata Kos-Kudła

Förderung

  • Medical University of Silesia

Zitieren

APA

Strzelczyk, J., Bocian-Jastrzębska, A., Strzelczyk, J. K., Wójcik-Giertuga, M., Biernacki, K., Kajdaniuk, D., & Kos-Kudła, B. (2024). Adipokines in Neuroendocrine Tumors: An Evaluation of the Serum Levels of Ghrelin and Leptin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189820

Vancouver

Strzelczyk J, Bocian-Jastrzębska A, Strzelczyk JK, Wójcik-Giertuga M, Biernacki K, Kajdaniuk D, et al. Adipokines in Neuroendocrine Tumors: An Evaluation of the Serum Levels of Ghrelin and Leptin. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189820

BibTeX
@article{Strzelczyk2024,
  author = {Strzelczyk, Janusz and Bocian-Jastrzębska, Agnes and Strzelczyk, Joanna Katarzyna and Wójcik-Giertuga, Monika and Biernacki, Krzysztof and Kajdaniuk, Dariusz and Kos-Kudła, Beata},
  title = {Adipokines in Neuroendocrine Tumors: An Evaluation of the Serum Levels of Ghrelin and Leptin},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25189820}
}
Kostenlos starten →